(Q39025627)

8 September 2017

A comparison of clinical features in tuberculosis associated with infection with human immunodeficiency viruses 1 and 2. (English)

1 reference

8 September 2017

1 reference

E Gnaore

1

1 reference

8 September 2017

M Sassan-Morokro

2

1 reference

8 September 2017

S Kassim

3

1 reference

8 September 2017

A Ackah

4

1 reference

8 September 2017

G Yesso

5

1 reference

8 September 2017

G Adjorlolo

6

1 reference

8 September 2017

H Digbeu

7

1 reference

8 September 2017

D Coulibaly

8

1 reference

8 September 2017

I M Coulibaly

9

1 reference

8 September 2017

R Doorly

10

1 reference

8 September 2017

1 January 1993

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

8 September 2017

1 reference

8 September 2017

87

1 reference

8 September 2017

1

1 reference

8 September 2017

57-59

1 reference

Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa

8 September 2017

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2893%2990420-U

Lymphadenopathy-associated virus type 2 in AIDS and AIDS-related complex. Clinical and virological features in four patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2893%2990420-U

Isolation of a new human retrovirus from West African patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2893%2990420-U

Human immunodeficiency virus type 2 infection associated with AIDS in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2893%2990420-U

Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2893%2990420-U

For debate. AIDS surveillance in Africa: a reappraisal of case definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2893%2990420-U

Clinical, hematologic, and immunologic cross-sectional evaluation of individuals exposed to human immunodeficiency virus type-2 (HIV-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2893%2990420-U

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2F0035-9203%2893%2990420-U

10.1016/0035-9203(93)90420-U

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference